Mark Stenhouse
Director/Board Member at PHATHOM PHARMACEUTICALS, INC.
Net worth: 95 580 $ as of 2024-03-30
Profile
Mark Stenhouse is an Independent Director at Phathom Pharmaceuticals, Inc. He previously worked as a Director at Prometheus Laboratories, Inc. from 2018 to 2020.
Mark also served as the Vice President-US Immunology at Abbott Laboratories from 2006 to 2010 and as the General Manager-Screening at EXACT Sciences Corp.
from 2019 to 2021.
Prior to that, he held the position of Vice President-U.S.
Immunology at AbbVie, Inc. from 2016 to 2018.
Mark's current job includes being the Chief Operating Officer at Prometheus Biosciences, Inc. from 2021 to 2023.
He completed his undergraduate degree at the College of Charleston.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-05-24 | 9,000 ( 0.02% ) | 95 580 $ | 2024-03-30 |
Mark Stenhouse active positions
| Companies | Position | Start |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Director/Board Member | 2020-03-16 |
Former positions of Mark Stenhouse
| Companies | Position | End |
|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Chief Operating Officer | 2023-06-15 |
| EXACT SCIENCES CORPORATION | Corporate Officer/Principal | 2020-12-31 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Director/Board Member | 2020-09-30 |
| ABBVIE INC. | Corporate Officer/Principal | 2018-02-28 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 2010-02-28 |
Training of Mark Stenhouse
| College of Charleston | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| EXACT SCIENCES CORPORATION | Health Technology |
| ABBVIE INC. | Health Technology |
| PHATHOM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
- Stock Market
- Insiders
- Mark Stenhouse
